Skip to main content
Equibles

Legal & General Group Plc

Position in ZVRA — Zevra Therapeutics, Inc.

CIK 764068 London, X0
Back to ZVRA Full portfolio

Position in ZVRA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$17,231,918
+$6,391,920 QoQ
Shares Held
1,201,668
+3.3% QoQ
Ownership
2.02%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 158 holders
Holding Since
Jun 2021
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZVRA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $3,299,239,490 across 292 Biotechnology names. ZVRA ranks #29 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,870,015 $928,892,550
2 REGN
Regeneron Pharmaceuticals, Inc.
 759,971 $473,872,316
3 ALNY
Alnylam Pharmaceuticals, Inc.
 924,561 $278,320,596
4 RPRX
Royalty Pharma plc
 3,800,504 $213,094,258
5 INCY
Incyte Corp
 1,605,980 $182,053,892
6 ARGX
Argenx SE
 177,164 $164,367,443
7 INSM
INSMED Inc
 826,431 $88,114,072
8 RVMD
Revolution Medicines, Inc.
 381,366 $71,422,223

All Filings in ZVRA

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $17,231,918 1,201,668
2026-03-31 $10,839,998 1,163,090
2025-12-31 $9,837,971 1,097,988
2025-09-30 $10,017,823 1,053,399
2025-06-30 $8,243,313 935,677
2025-03-31 $5,525,650 737,737
2024-12-31 $44,210 5,301
2024-09-30 $31,500 4,539
2024-06-30 $18,869 3,851
2024-03-31 $19,285 3,325
2023-12-31 $21,778 3,325
2023-09-30 $16,026 3,325
2023-06-30 $16,957 3,325
2022-03-31 $13,289 2,642
2021-12-31 $23,011 2,642
2021-09-30 $24,649 2,642
2021-06-30 $33,870 2,642